On the public citation graph
Discovery of Novel Agonists and Antagonists of the Free Fatty Acid Receptor 1 (FFAR1) Using Virtual Screening
0 signed · 166 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/jcc.540110405openalex-snapshot
Macromodel—an integrated software system for modeling organic and bioorganic molecules using molecular mechanics
inferredcites →https://doi.org/10.1016/j.bmcl.2006.01.007openalex-snapshot
Synthesis and activity of small molecule GPR40 agonists
inferredcites →https://doi.org/10.1016/j.cmet.2005.03.007openalex-snapshot
The FFA receptor GPR40 links hyperinsulinemia, hepatic steatosis, and impaired glucose homeostasis in mouse
inferredcites →https://doi.org/10.1016/s1093-3263(00)00073-5openalex-snapshot
Library design using BCUT chemistry-space descriptors and multiple four-point pharmacophore fingerprints: simultaneous optimization and structure-based diversity
inferredcites →https://doi.org/10.1021/ci00017a025openalex-snapshot
Flexible 3D searching: The directed tweak technique
inferredcites →https://doi.org/10.1021/ci049714+openalex-snapshot
ZINC − A Free Database of Commercially Available Compounds for Virtual Screening
inferredcites →https://doi.org/10.1021/jm030085popenalex-snapshot
Molecular Modeling of the Three-Dimensional Structure of Dopamine 3 (D3) Subtype Receptor: Discovery of Novel and Potent D3Ligands through a Hybrid Pharmacophore- and Structure-Based Database Searching Approach
inferredcites →https://doi.org/10.1021/jm0311487openalex-snapshot
Successful Virtual Screening for a Submicromolar Antagonist of the Neurokinin-1 Receptor Based on a Ligand-Supported Homology Model
inferredcites →https://doi.org/10.1021/jm050090oopenalex-snapshot
Virtual Screening of Biogenic Amine-Binding G-Protein Coupled Receptors: Comparative Evaluation of Protein- and Ligand-Based Virtual Screening Protocols
inferredcites →https://doi.org/10.1021/jm0508641openalex-snapshot
An Integrated in Silico 3D Model-Driven Discovery of a Novel, Potent, and Selective Amidosulfonamide 5-HT1A Agonist (PRX-00023) for the Treatment of Anxiety and Depression
inferredcites →https://doi.org/10.1021/jm051256oopenalex-snapshot
Extra Precision Glide: Docking and Scoring Incorporating a Model of Hydrophobic Enclosure for Protein−Ligand Complexes
inferredcites →https://doi.org/10.1021/jm061389popenalex-snapshot
Identification of Nonpeptide CCR5 Receptor Agonists by Structure-based Virtual Screening
inferredcites →https://doi.org/10.1021/jm0614782openalex-snapshot
Bidirectional, Iterative Approach to the Structural Delineation of the Functional “Chemoprint” in GPR40 for Agonist Recognition
inferredcites →https://doi.org/10.1021/jm070130jopenalex-snapshot
Synthesis and Biological Evaluation of 3-Aryl-3-(4-phenoxy)-propionic Acid as a Novel Series of G Protein-Coupled Receptor 40 Agonists
inferredcites →https://doi.org/10.1038/nature01478openalex-snapshot
Free fatty acids regulate insulin secretion from pancreatic β cells through GPR40
inferredcites →https://doi.org/10.1038/sj.bjp.0706770openalex-snapshot
Pharmacological regulation of insulin secretion in MIN6 cells through the fatty acid receptor GPR40: identification of agonist and antagonist small molecules
inferredcites →https://doi.org/10.1073/pnas.0401862101openalex-snapshot
G protein-coupled receptors: In silico drug discovery in 3D
inferredcites →https://doi.org/10.1074/jbc.m600440200openalex-snapshot
Low Affinity Analogs of Thyrotropin-releasing Hormone Are Super-agonists
inferredcites →https://doi.org/10.1074/jbc.m601389200openalex-snapshot
Predictions of CCR1 Chemokine Receptor Structure and BX 471 Antagonist Binding Followed by Experimental Validation
inferredcites →https://doi.org/10.1074/jbc.m705077200openalex-snapshot
Identification of Residues Important for Agonist Recognition and Activation in GPR40
inferredcites →https://doi.org/10.1517/14728222.11.5.661openalex-snapshot
Fatty acid receptors as new therapeutic targets for diabetes
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.1002/0471266949.bmc123openalex-snapshot
GPCR Homology Model Development and Application
inferred← citeshttps://doi.org/10.1002/9783527633326.ch14openalex-snapshot
Virtual Screening on Homology Models
inferred← citeshttps://doi.org/10.1002/ardp.200800096openalex-snapshot
Fatty Acid Binding Receptors and Their Physiological Role in Type 2 Diabetes
inferred← citeshttps://doi.org/10.1002/ardp.70335openalex-snapshot
Trends in Developing PPAR‐Gamma and FFAR1/GPCR40 Modulators for Managing Type‐II Diabetes Mellitus
inferred← citeshttps://doi.org/10.1002/cmdc.200800129openalex-snapshot
Integrating Structure‐ and Ligand‐Based Virtual Screening: Comparison of Individual, Parallel, and Fused Molecular Docking and Similarity Search Calculations on Multiple Targets
inferred← citeshttps://doi.org/10.1002/cmdc.201100317openalex-snapshot
Structure‐Based Discovery of Allosteric Modulators of Two Related Class B G‐Protein‐Coupled Receptors
inferred← citeshttps://doi.org/10.1002/ddr.21078openalex-snapshot
A Hybrid Structure/Pharmacophore‐Based Virtual Screening Approach to Design Potential Leads: A Computer‐Aided Design of S outh A frican HIV ‐1 Subtype C Protease Inhibitors
inferred← citeshttps://doi.org/10.1002/jcc.21346openalex-snapshot
Ligand and structure‐based models for the prediction of ligand‐receptor affinities and virtual screenings: Development and application to the β2‐adrenergic receptor
inferred← citeshttps://doi.org/10.1002/med.20142openalex-snapshot
Recent and emerging anti‐diabetes targets
inferred← citeshttps://doi.org/10.1002/med.21441openalex-snapshot
Free Fatty Acid Receptor 1 (FFAR1) as an Emerging Therapeutic Target for Type 2 Diabetes Mellitus: Recent Progress and Prevailing Challenges
inferred← citeshttps://doi.org/10.1007/164_2016_52openalex-snapshot
Application of GPCR Structures for Modelling of Free Fatty Acid Receptors
inferred← citeshttps://doi.org/10.1007/164_2016_59openalex-snapshot
Ligands at Free Fatty Acid Receptor 1 (GPR40)
inferred← citeshttps://doi.org/10.1007/164_2016_60openalex-snapshot
Pharmacological Tool Compounds for the Free Fatty Acid Receptor 4 (FFA4/GPR120)
inferred← citeshttps://doi.org/10.1007/978-1-60761-762-4_23openalex-snapshot
The Family of G Protein-Coupled Receptors: An Example of Membrane Proteins
inferred← citeshttps://doi.org/10.1007/978-1-60761-839-3_15openalex-snapshot
Beyond Rhodopsin: G Protein-Coupled Receptor Structure and Modeling Incorporating the β2-adrenergic and Adenosine A2A Crystal Structures
inferred← citeshttps://doi.org/10.1007/978-1-62703-023-6_15openalex-snapshot
Target Based Virtual Screening by Docking into Automatically Generated GPCR Models
inferred← citeshttps://doi.org/10.1007/978-1-62703-023-6_16openalex-snapshot
Predicting the Biological Activities Through QSAR Analysis and Docking-Based Scoring
inferred← citeshttps://doi.org/10.1007/978-94-007-7423-0_7openalex-snapshot
From Three-Dimensional GPCR Structure to Rational Ligand Discovery
inferred← citeshttps://doi.org/10.1007/978-981-15-8936-2_10openalex-snapshot
In Silico Approach in Drug Design and Drug Discovery: An Update
inferred← citeshttps://doi.org/10.1007/s00044-013-0842-7openalex-snapshot
Virtual screening based on pharmacophoric features of known calpain inhibitors to identify potent inhibitors of calpain
inferred← citeshttps://doi.org/10.1007/s00894-011-1328-5openalex-snapshot
Pharmacophore modeling and virtual screening studies to identify new c-Met inhibitors
inferred← citeshttps://doi.org/10.1007/s10822-008-9218-3openalex-snapshot
Ligand and structure-based methodologies for the prediction of the activity of G protein-coupled receptor ligands
inferred← citeshttps://doi.org/10.1007/s10822-017-0011-zopenalex-snapshot
Ligand-based virtual screening under partial shape constraints
inferred← citeshttps://doi.org/10.1007/s11030-013-9493-3openalex-snapshot
An efficient multistep ligand-based virtual screening approach for GPR40 agonists
inferred← citeshttps://doi.org/10.1007/s12010-017-2625-yopenalex-snapshot
Discovery of Potent Neuraminidase Inhibitors Using a Combination of Pharmacophore-Based Virtual Screening and Molecular Simulation Approach
inferred← citeshttps://doi.org/10.1007/s12013-018-0844-7openalex-snapshot
Hyphenated 3D-QSAR statistical model-drug repurposing analysis for the identification of potent neuraminidase inhibitor
inferred← citeshttps://doi.org/10.1016/b978-0-12-381517-0.00005-9openalex-snapshot
The Emerging Role of Promiscuous 7TM Receptors as Chemosensors for Food Intake
inferred← citeshttps://doi.org/10.1016/b978-0-12-385952-5.00006-3openalex-snapshot
Experimental Challenges to Targeting Poorly Characterized GPCRs: Uncovering the Therapeutic Potential for Free Fatty Acid Receptors
inferred← citeshttps://doi.org/10.1016/b978-0-12-407865-9.00014-5openalex-snapshot
Application of Monte Carlo-Based Receptor Ensemble Docking to Virtual Screening for GPCR Ligands
inferred← citeshttps://doi.org/10.1016/b978-0-12-407865-9.00015-7openalex-snapshot
From Heptahelical Bundle to Hits from the Haystack
inferred← citeshttps://doi.org/10.1016/b978-0-12-409547-2.11305-8openalex-snapshot
Applications of Pharmacophore Mapping☆
inferred← citeshttps://doi.org/10.1016/b978-0-12-409547-2.12358-3openalex-snapshot
Modeling and Design for Membrane Protein Targets
inferred← citeshttps://doi.org/10.1016/b978-0-12-816228-6.00015-5openalex-snapshot
Computer-aided GPCR drug discovery
inferred← citeshttps://doi.org/10.1016/bs.mcb.2015.11.007openalex-snapshot
What can simulations tell us about GPCRs
inferred← citeshttps://doi.org/10.1016/j.bbrc.2009.10.004openalex-snapshot
A novel class of antagonists for the FFAs receptor GPR40
inferred← citeshttps://doi.org/10.1016/j.biopha.2010.06.008openalex-snapshot
DC260126, a small-molecule antagonist of GPR40, improves insulin tolerance but not glucose tolerance in obese Zucker rats
inferred← citeshttps://doi.org/10.1016/j.bmc.2015.09.010openalex-snapshot
Design, synthesis and structure–activity relationship studies of novel phenoxyacetamide-based free fatty acid receptor 1 agonists for the treatment of type 2 diabetes
inferred← citeshttps://doi.org/10.1016/j.bmc.2017.03.001openalex-snapshot
Design, synthesis and structure–activity relationship studies of novel free fatty acid receptor 1 agonists bearing amide linker
inferred← citeshttps://doi.org/10.1016/j.bmcl.2008.10.085openalex-snapshot
Discovery of diacylphloroglucinols as a new class of GPR40 (FFAR1) agonists
inferred← citeshttps://doi.org/10.1016/j.bmcl.2009.10.052openalex-snapshot
Discovery of 5-aryloxy-2,4-thiazolidinediones as potent GPR40 agonists
inferred← citeshttps://doi.org/10.1016/j.bmcl.2014.07.043openalex-snapshot
Homology modeling and explicit membrane molecular dynamics simulation to delineate the mode of binding of thiazolidinediones into FFAR1 and the mechanism of receptor activation
inferred← citeshttps://doi.org/10.1016/j.bmcl.2018.03.051openalex-snapshot
Synthesis, biological evaluation, and molecular docking investigation of benzhydrol- and indole-based dual PPAR-γ/FFAR1 agonists
inferred← citeshttps://doi.org/10.1016/j.copbio.2009.08.003openalex-snapshot
Docking and chemoinformatic screens for new ligands and targets
inferred← citeshttps://doi.org/10.1016/j.coph.2016.09.001openalex-snapshot
Gut hormone GPCRs: structure, function, drug discovery
inferred← citeshttps://doi.org/10.1016/j.ddtec.2012.05.002openalex-snapshot
C(X)CR in silico: Computer-aided prediction of chemokine receptor–ligand interactions
inferred← citeshttps://doi.org/10.1016/j.ejmech.2008.09.016openalex-snapshot
Virtual screening for Raf-1 kinase inhibitors based on pharmacophore model of substituted ureas
inferred← citeshttps://doi.org/10.1016/j.ejmech.2015.12.049openalex-snapshot
Design, synthesis, and biological evaluation of novel thiazolidinediones as PPARγ/FFAR1 dual agonists
inferred← citeshttps://doi.org/10.1016/j.jmgm.2010.02.001openalex-snapshot
Molecular docking and molecular dynamics simulation studies of GPR40 receptor–agonist interactions
inferred← citeshttps://doi.org/10.1016/j.jmgm.2010.11.005openalex-snapshot
Docking-based virtual screening for ligands of G protein-coupled receptors: Not only crystal structures but also in silico models
inferred← citeshttps://doi.org/10.1016/j.jpba.2019.03.040openalex-snapshot
Pharmacokinetics and metabolism of GW9508 in rat by liquid chromatography/electrospray ionization tandem mass spectrometry
inferred← citeshttps://doi.org/10.1016/j.neuropharm.2019.107899openalex-snapshot
GW9508 ameliorates cognitive impairment via the cAMP-CREB and JNK pathways in APPswe/PS1dE9 mouse model of Alzheimer's disease
inferred← citeshttps://doi.org/10.1016/j.sbi.2013.01.008openalex-snapshot
Modeling G protein-coupled receptors and their interactions with ligands
inferred← citeshttps://doi.org/10.1016/j.tips.2014.10.009openalex-snapshot
Computational studies to predict or explain G protein coupled receptor polypharmacology
inferred← citeshttps://doi.org/10.1016/j.ymeth.2014.07.007openalex-snapshot
Hierarchical virtual screening approaches in small molecule drug discovery
inferred← citeshttps://doi.org/10.1021/acs.chemrev.6b00056openalex-snapshot
Complex Pharmacology of Free Fatty Acid Receptors
inferred← citeshttps://doi.org/10.1021/acs.jcim.5b00066openalex-snapshot
Structure-Based Prediction of G-Protein-Coupled Receptor Ligand Function: A β-Adrenoceptor Case Study
inferred← citeshttps://doi.org/10.1021/acs.jcim.5b00559openalex-snapshot
ZINC 15 – Ligand Discovery for Everyone
inferred← citeshttps://doi.org/10.1021/acs.jcim.9b00279openalex-snapshot
BRUSELAS: HPC Generic and Customizable Software Architecture for 3D Ligand-Based Virtual Screening of Large Molecular Databases
inferred← citeshttps://doi.org/10.1021/acsmedchemlett.7b00460openalex-snapshot
SAR Studies of Indole-5-propanoic Acid Derivatives To Develop Novel GPR40 Agonists
inferred← citeshttps://doi.org/10.1021/ci200481copenalex-snapshot
Virtual Drug Screen Schema Based on Multiview Similarity Integration and Ranking Aggregation
inferred← citeshttps://doi.org/10.1021/ci300463gopenalex-snapshot
Boosting Virtual Screening Enrichments with Data Fusion: Coalescing Hits from Two-Dimensional Fingerprints, Shape, and Docking
inferred← citeshttps://doi.org/10.1021/ci800322yopenalex-snapshot
Similarity Searching Using Fingerprints of Molecular Fragments Involved in Protein−Ligand Interactions
inferred← citeshttps://doi.org/10.1021/cr100437topenalex-snapshot
Update 1 of: Computational Modeling Approaches to Structure–Function Analysis of G Protein-Coupled Receptors
inferred← citeshttps://doi.org/10.1021/cr300314qopenalex-snapshot
Integrated Approach to Structure-Based Enzymatic Drug Design: Molecular Modeling, Spectroscopy, and Experimental Bioactivity
inferred← citeshttps://doi.org/10.1021/jm2005699openalex-snapshot
Identification of a Potent and Selective Free Fatty Acid Receptor 1 (FFA1/GPR40) Agonist with Favorable Physicochemical and in Vitro ADME Properties
inferred← citeshttps://doi.org/10.1021/jm2011589openalex-snapshot
Crystal Structure-Based Virtual Screening for Fragment-like Ligands of the Human Histamine H 1 Receptor
inferred← citeshttps://doi.org/10.1021/jm301470aopenalex-snapshot
Discovery of a Potent and Selective Free Fatty Acid Receptor 1 Agonist with Low Lipophilicity and High Oral Bioavailability
inferred← citeshttps://doi.org/10.1021/jm400307yopenalex-snapshot
Optimized Method of G-Protein-Coupled Receptor Homology Modeling: Its Application to the Discovery of Novel CXCR7 Ligands
inferred← citeshttps://doi.org/10.1021/jm800710xopenalex-snapshot
Selective Structure-Based Virtual Screening for Full and Partial Agonists of the β2 Adrenergic Receptor
inferred← citeshttps://doi.org/10.1021/jm800970bopenalex-snapshot
Identification of G protein-coupled receptor 120-selective agonists derived from PPARγ agonists
inferred← citeshttps://doi.org/10.1021/jm8010178openalex-snapshot
Discovery of Potent and Selective Agonists for the Free Fatty Acid Receptor 1 (FFA1/GPR40), a Potential Target for the Treatment of Type II Diabetes
inferred← citeshttps://doi.org/10.1021/jm9001346openalex-snapshot
Sequence-Derived Three-Dimensional Pharmacophore Models for G-Protein-Coupled Receptors and Their Application in Virtual Screening
inferred← citeshttps://doi.org/10.1021/ml100106copenalex-snapshot
Structure−Activity Study of Dihydrocinnamic Acids and Discovery of the Potent FFA1 (GPR40) Agonist TUG-469
inferred← citeshttps://doi.org/10.1038/nchembio.662openalex-snapshot
Ligand discovery from a dopamine D3 receptor homology model and crystal structure
inferred← citeshttps://doi.org/10.1038/nrd3777openalex-snapshot
G protein-coupled receptors for energy metabolites as new therapeutic targets
inferred← citeshttps://doi.org/10.1038/s41596-021-00597-zopenalex-snapshot
A practical guide to large-scale docking
inferred← citeshttps://doi.org/10.1038/s41598-020-73467-5openalex-snapshot
FFA2-, but not FFA3-agonists inhibit GSIS of human pseudoislets: a comparative study with mouse islets and rat INS-1E cells
inferred← citeshttps://doi.org/10.1038/srep28288openalex-snapshot
Function-specific virtual screening for GPCR ligands using a combined scoring method
inferred← citeshttps://doi.org/10.1039/c5cc05050bopenalex-snapshot
Expanding the horizons of G protein-coupled receptor structure-based ligand discovery and optimization using homology models
inferred← citeshttps://doi.org/10.1073/pnas.1120431109openalex-snapshot
Structure-based ligand discovery for the protein–protein interface of chemokine receptor CXCR4
inferred← citeshttps://doi.org/10.1074/jbc.m109.012849openalex-snapshot
The Action and Mode of Binding of Thiazolidinedione Ligands at Free Fatty Acid Receptor 1
inferred← citeshttps://doi.org/10.1074/jbc.m805601200openalex-snapshot
Conserved Polar Residues in Transmembrane Domains V, VI, and VII of Free Fatty Acid Receptor 2 and Free Fatty Acid Receptor 3 Are Required for the Binding and Function of Short Chain Fatty Acids
inferred← citeshttps://doi.org/10.1074/jbc.m806987200openalex-snapshot
Two Arginine-Glutamate Ionic Locks Near the Extracellular Surface of FFAR1 Gate Receptor Activation
inferred← citeshttps://doi.org/10.1074/jbc.r800014200openalex-snapshot
Seven Transmembrane-spanning Receptors for Free Fatty Acids as Therapeutic Targets for Diabetes Mellitus: Pharmacological, Phylogenetic, and Drug Discovery Aspects
inferred← citeshttps://doi.org/10.1080/08927022.2012.751592openalex-snapshot
Pharmacophore models generation by catalyst and phase consensus-based virtual screening protocol against PI3Kα inhibitors
inferred← citeshttps://doi.org/10.1093/nar/gkn618openalex-snapshot
SuperSite: dictionary of metabolite and drug binding sites in proteins
inferred← citeshttps://doi.org/10.1096/fj.12-213314openalex-snapshot
Chemically engineering ligand selectivity at the free fatty acid receptor 2 based on pharmacological variation between species orthologs
inferred← citeshttps://doi.org/10.1111/bph.12879openalex-snapshot
Characterizing pharmacological ligands to study the long‐chain fatty acid receptors GPR 40/ FFA 1 and GPR 120/ FFA 4
inferred← citeshttps://doi.org/10.1111/bph.13452openalex-snapshot
Identifying ligands at orphan GPCRs: current status using structure‐based approaches
inferred← citeshttps://doi.org/10.1111/cbdd.13611openalex-snapshot
Discovery of small molecule agonists targeting neuropeptide Y4 receptor using homology modeling and virtual screening
inferred← citeshttps://doi.org/10.1111/j.1476-5381.2009.00421.xopenalex-snapshot
Agonism and allosterism: the pharmacology of the free fatty acid receptors FFA2 and FFA3
inferred← citeshttps://doi.org/10.1111/j.1476-5381.2010.01145.xopenalex-snapshot
Pharmacological characterization of the cytoprotective effects of polyunsaturated fatty acids in insulin‐secreting BRIN‐BD11 cells
inferred← citeshttps://doi.org/10.1111/j.1747-0285.2009.00829.xopenalex-snapshot
Utilizing Target–Ligand Interaction Information in Fingerprint Searching for Ligands of Related Targets
inferred← citeshttps://doi.org/10.1111/j.1747-0285.2010.01007.xopenalex-snapshot
Computational Methodologies for Compound Database Searching that Utilize Experimental Protein–Ligand Interaction Information
inferred← citeshttps://doi.org/10.1124/mol.109.055244openalex-snapshot
Molecular Pharmacology of Promiscuous Seven Transmembrane Receptors Sensing Organic Nutrients
inferred← citeshttps://doi.org/10.1124/mol.112.079335openalex-snapshot
New Insights for Drug Design from the X-Ray Crystallographic Structures of G-Protein-Coupled Receptors
inferred← citeshttps://doi.org/10.1124/mol.115.099663openalex-snapshot
A Molecular Pharmacologist’s Guide to G Protein–Coupled Receptor Crystallography
inferred← citeshttps://doi.org/10.1124/pr.108.00802openalex-snapshot
International Union of Pharmacology. LXXI. Free Fatty Acid Receptors FFA1, -2, and -3: Pharmacology and Pathophysiological Functions
inferred← citeshttps://doi.org/10.1146/annurev-pharmtox-011613-135945openalex-snapshot
Free Fatty Acid (FFA) and Hydroxy Carboxylic Acid (HCA) Receptors
inferred← citeshttps://doi.org/10.11606/t.42.2014.tde-18112014-131712openalex-snapshot
Participação do GPR40 na ativação da NADPH oxidase na linhagem celular BRIN-BD11.
inferred← citeshttps://doi.org/10.1186/s12900-015-0044-2openalex-snapshot
Free fatty acid receptors: structural models and elucidation of ligand binding interactions
inferred← citeshttps://doi.org/10.1208/s12248-009-9094-3openalex-snapshot
Recent Advances in Structure-Based Virtual Screening of G-Protein Coupled Receptors
inferred← citeshttps://doi.org/10.1371/journal.pone.0027270openalex-snapshot
AMG 837: A Novel GPR40/FFA1 Agonist that Enhances Insulin Secretion and Lowers Glucose Levels in Rodents
inferred← citeshttps://doi.org/10.1371/journal.pone.0046300openalex-snapshot
A Potent Class of GPR40 Full Agonists Engages the EnteroInsular Axis to Promote Glucose Control in Rodents
inferred← citeshttps://doi.org/10.1371/journal.pone.0075992openalex-snapshot
Ligand Pose and Orientational Sampling in Molecular Docking
inferred← citeshttps://doi.org/10.1517/13543770802665717openalex-snapshot
Progress in the discovery and development of small-molecule modulators of G-protein-coupled receptor 40 (GPR40/FFA1/FFAR1): an emerging target for type 2 diabetes
inferred← citeshttps://doi.org/10.1517/17460441.3.5.579openalex-snapshot
Designing a ligand for pharmaceutical purposes
inferred← citeshttps://doi.org/10.1517/17460441003592072openalex-snapshot
Pharmacophore-based virtual screening: a review of recent applications
inferred← citeshttps://doi.org/10.18632/oncotarget.20665openalex-snapshot
Discovery of novel frizzled-7 inhibitors by targeting the receptor’s transmembrane domain
inferred← citeshttps://doi.org/10.2174/09298673113209990001openalex-snapshot
Virtual Screening Strategies in Drug Discovery: A Critical Review
inferred← citeshttps://doi.org/10.2174/09298673113209990168openalex-snapshot
Free Fatty Acids-Sensing G Protein-Coupled Receptors in Drug Targeting and Therapeutics
inferred← citeshttps://doi.org/10.2174/0929867329666220927113614openalex-snapshot
Free Fatty Acid Receptors (FFARs): Emerging Therapeutic Targets for the Management of Diabetes Mellitus
inferred← citeshttps://doi.org/10.2174/138161209789824786openalex-snapshot
Customizing G Protein-Coupled Receptor Models for Structure-Based Virtual Screening
inferred← citeshttps://doi.org/10.2174/138161209789824803openalex-snapshot
Unraveling the Structure and Function of G Protein-Coupled Receptors Through NMR Spectroscopy
inferred← citeshttps://doi.org/10.2174/1389557520666201023141326openalex-snapshot
Recent Updates on Free Fatty Acid Receptor 1 (GPR-40) Agonists for the Treatment of Type 2 Diabetes Mellitus
inferred← citeshttps://doi.org/10.2174/156802609788897871openalex-snapshot
Computer-Aided Identification of Ligands for GPCR Anti-Obesity Targets
inferred← citeshttps://doi.org/10.2174/156802609789207091openalex-snapshot
Docking Screens: Right for the Right Reasons?
inferred← citeshttps://doi.org/10.2174/156802610791164210openalex-snapshot
Understanding Functional Residues of the Cannabinoid CB1 Receptor for Drug Discovery
inferred← citeshttps://doi.org/10.2174/15680266113139990028openalex-snapshot
Recent Trends and Future Prospects in Computational GPCR Drug Discovery: From Virtual Screening to Polypharmacology
inferred← citeshttps://doi.org/10.2174/1871527318666191114093749openalex-snapshot
Omega-3 Fatty Acids as Druggable Therapeutics for Neurodegenerative Disorders
inferred← citeshttps://doi.org/10.32657/10356/69603openalex-snapshot
Exploiting receptor flexibility to improve the accuracy of structure-based virtual screening
inferred← citeshttps://doi.org/10.3389/fendo.2012.00001openalex-snapshot
Low Affinity GPCRs for Metabolic Intermediates: Challenges for Pharmacologists
inferred← citeshttps://doi.org/10.3389/fendo.2012.00111openalex-snapshot
Short-chain free fatty acid receptors FFA2/GPR43 and FFA3/GPR41 as new potential therapeutic targets
inferred← citeshttps://doi.org/10.3389/fphar.2015.00100openalex-snapshot
Advancements in therapeutically targeting orphan GPCRs
inferred← citeshttps://doi.org/10.3389/fphar.2023.1197743openalex-snapshot
Oral administration of linoleic acid immediately before glucose load ameliorates postprandial hyperglycemia
inferred← citeshttps://doi.org/10.3390/ijms19072105openalex-snapshot
Recent Trends and Applications of Molecular Modeling in GPCR–Ligand Recognition and Structure-Based Drug Design
inferred← citeshttps://doi.org/10.3390/molecules24152747openalex-snapshot
Combined Ensemble Docking and Machine Learning in Identification of Therapeutic Agents with Potential Inhibitory Effect on Human CES1
inferred← citeshttps://doi.org/10.3390/ph16020317openalex-snapshot
Computational Chemistry for the Identification of Lead Compounds for Radiotracer Development
inferred← citeshttps://doi.org/10.4155/fmc.11.18openalex-snapshot
Integrating Structure-Based and Ligand-Based Approaches for Computational Drug Design
inferred← citeshttps://doi.org/10.4155/fmc.11.24openalex-snapshot
The Use of G-Protein Coupled Receptor Models in Lead Optimization
inferred← citeshttps://doi.org/10.53846/goediss-3829openalex-snapshot
Development and application of NMR methods for challenges in drug discovery
inferred← citeshttps://doi.org/10.58830/ozgur.pub393.c1553openalex-snapshot
Bilgisayar Destekli İlaç Tasarımı ve Tasarımın Ticari Ürün Örneklerine Kısa Bir Bakış
inferred← citeshttps://doi.org/10.58830/ozgur.pub393.c1554openalex-snapshot
Yeşil Sentez: Nano Partiküller ve Potansiyel Uygulama Alanları
inferred← citeshttps://doi.org/10.58830/ozgur.pub393.c1555openalex-snapshot
Recent Developments in Benzimidazole Derivatives (2023)
inferred← citeshttps://doi.org/10.58830/ozgur.pub393.c1556openalex-snapshot
β-Sülfonil Ketonların Sentez Yöntemleri
inferred← citeshttps://doi.org/10.58830/ozgur.pub393.c1557openalex-snapshot
Nanobiyoteknoloji ile Sürdürülebilir Bitki Sağlığı ve Çevre Yönetimi
inferred← citeshttps://doi.org/10.58830/ozgur.pub393.c1558openalex-snapshot
Nanoteknoloji ve Organik Kimya
inferred← citeshttps://doi.org/10.58830/ozgur.pub393.c1559openalex-snapshot
Nanotechnology and Current Applications in Biotechnology
inferred← citeshttps://doi.org/10.58830/ozgur.pub393.c1560openalex-snapshot
Biyoaktif Bileşiklerin Elektrospinning Yöntemi İle Nanoenkapsülasyonu
inferred← citeshttps://doi.org/10.58830/ozgur.pub393.c1561openalex-snapshot
Astım ve Lökotrien Reseptör Antagonistleri
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.